Zheng Quan Shi Bao Wang·2025-11-20 09:27Group 1 - 42 stocks received buy ratings from institutions today, with China Haicheng and Zhongheng Electric being the most followed, each having one buy rating record [1] - Among the stocks rated by institutions, 18 provided future target prices, with 15 stocks showing an upside potential of over 20%. China International Capital Corporation (CICC) has the highest upside potential at 61.08% for Huatai Securities, with a target price of 56.20 CNY [1] - The average performance of stocks with buy ratings today was a decline of 0.75%, underperforming the Shanghai Composite Index. Notable gainers included Tongyu Communication and Huhua Electric, with increases of 2.80% and 2.14% respectively [1] Group 2 - The pharmaceutical and biotechnology sector is the most favored, with 15 stocks including Baipu Sais and Maipu Medical listed among the buy-rated stocks. The food and beverage and telecommunications sectors also received attention, with 5 and 4 stocks respectively [2] - Specific stocks with buy ratings include: - Zhaoyi Innovation (260.00 CNY target price, latest close at 199.10 CNY) - United Imaging Healthcare (167.00 CNY target price, latest close at 130.69 CNY) - Kailai Ying (120.00 CNY target price, latest close at 91.00 CNY) - Maipu Medical (89.00 CNY target price, latest close at 64.96 CNY) - BGI Genomics (80.00 CNY target price, latest close at 61.04 CNY) [2][3] Group 3 - New stocks receiving institutional attention include Lankai Technology and Shengtun Mining, marking their first ratings [1] - The average target price for the stocks rated today indicates significant upside potential, with notable mentions including Wens Foodstuffs (25.00 CNY target price, latest close at 17.42 CNY) and Hengli Petrochemical (27.00 CNY target price, latest close at 19.07 CNY) [2][3]